Literature DB >> 12110292

Cyclic nucleotide-independent phosphorylation of vitellin by casein kinase II purified from Rhodnius prolixus oocytes.

Mário A C Silva-Neto1, Eliane Fialho, Márcia C Paes, Pedro L Oliveira, Hatisaburo Masuda.   

Abstract

In this study we show that Vitellin (VT) phosphorylation in chorionated oocytes of Rhodnius prolixus is completely inhibited by heparin (10 microg/ml), a classical casein kinase II (CK II) inhibitor. VT phosphorylation is not affected by modulators of cyclic nucleotide-dependent protein kinases such as c-AMP (10 microM), H-8 (1 microM) and H-89 (0.1 microM). We have obtained a 3000-fold VT-free enriched preparation of CK II. Autophosphorylation of this enzyme preparation in the presence of (32)P-ATP demonstrated that it lacks any endogenous substrates. Rhodnius CK II is strongly inhibited by heparin (Ki = 9 nM) and uses ATP (Km = 36 microM) or GTP (Km = 86 microM) as phosphate donors. Incubation of VT with purified Rhodnius CK II and (32)P-ATP led to the incorporation of 2 mols of phosphate/mol VT. However, the total number of phosphorylation sites available can be altered by previous incubation of VT with alkaline phosphatase. These data show that an insect yolk protein contain phosphorylation sites for a cyclic nucleotide-independent protein kinase such as CK II.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110292     DOI: 10.1016/s0965-1748(01)00173-4

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  2 in total

1.  Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors.

Authors:  Monika Janeczko; Maciej Masłyk; Ryszard Szyszka; Andrea Baier
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

2.  A vitellogenin polyserine cleavage site: highly disordered conformation protected from proteolysis by phosphorylation.

Authors:  Heli Havukainen; Jarl Underhaug; Florian Wolschin; Gro Amdam; Øyvind Halskau
Journal:  J Exp Biol       Date:  2012-06-01       Impact factor: 3.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.